title: Total mesorectal excision for the treatment of rectal cancer.
abstract: BACKGROUND
  In the surgical treatment of rectal cancer, a clear circumferential resection margin and distal resection margin should be obtained. The aim of this study was to determine the morbidity, mortality, survival outcome, and local failure after total mesorectal excision (TME) in the surgical treatment of rectal cancer.
  
  
  METHODS
  This retrospective study was conducted on 101 patients treated for rectal cancer using low anterior resection (LAR), abdominoperinial resection (APR), or Hartmaan's technique. In all operative procedures, total mesorectal excisions (TMEs) were done. The patients were treated from November 2000 to April 2011 in the South Egypt Cancer Institute (SECI) of Assuit University (Egypt). Neo-adjuvant therapy was given to those patients with serosalin filtration, lymph node involvement, and sexual and urinary function impairment. Data were analyzed using IBM-SPSS version 21, and survival rates were estimated using the Kaplan-Meier method.
  
  
  RESULTS
  One hundred one patients were evaluable (61 males, 40 females). Regarding the operative procedure used, it was: (APR), LAR, Hartmaan's technique in 15.8%, 71.3%, and 12.9% of patients, respectively. Operation-related mortality during the 30 days after surgery was 3%. The operations resulted in morbidity in 25% of the patients, anastomotic site leak in 5.9% of the patients, urinary dysfynction in 9.9% of the patients, and erectile dysfunction in 15.8% of the male patients. Regarding safety margin, the median distances were distal/radial margin, 23/12 mm, distal limit 7 cm. Median lymph nodes harvest 19 nodes. Primary tumor locations were anteriorly 23.8%, laterally 13.9%, posteriorly 38.6%, and circumferential 23.8%. Protective stoma 16.8%. Primary Tumor TNM classification (T1, T2, T3, and T4; 3, 28.7, 55.4, and 12.9%, respectively). Nodes Metastases (N0, N1, and N2; 57.4, 31.7, and 10.9%, respectively). TNM staging (I, II, III, and IV; 15.8, 29.7, 46.5, and 7.9%, respectively). Chemotherapy was administered to 67.3% of the patients. Radiotherapy (short course neoadjuvant, long course neoadjuvant, and adjuvant postoperative used in 33.7, 20.8, and 19.8% of patients, respectively). Survival 5-years CSS was 73% and 5-years RFS 71%. Mean operative time was 213 minutes. The average amount of intraoperative blood loss was 344 mL.
  
  
  CONCLUSIONS
  Total mesorectal excision (TME) represents the gold-standard technique in rectal cancer surgery. It is safe with neoadjuvent chemoradiotherapy and provides both maximal oncological efficiency (local control and long-term survival and maintenance of a good quality of life).
authors.affiliation: M.D., Lecturer of Surgical Oncology, Department of Surgical oncology, South Egypt Cancer Institute, Assiut University, Assuit, Egypt.
authors.forename: Ali
authors.initials: A
authors.lastname: Zedan
authors.affiliation: M.D., Lecturer of Clinical Oncology, Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Assiut University, Assuit, Egypt.
authors.forename: Tareq
authors.initials: T
authors.lastname: Salah
keywords: mesorectal excision; neoadjuvent chemoradiotherapy; rectal cancer
references.citation: Ann Surg. 2005 May;241(5):829-36; discussion 836-8
references.pmid: 15849519
references.citation: World J Gastroenterol. 2012 Dec 28;18(48):7308-13
references.pmid: 23326138
references.citation: Ann Acad Med Singapore. 2011 Oct;40(10):460-6
references.pmid: 22206055
references.citation: Ann Surg Oncol. 2010 Feb;17(2):441-7
references.pmid: 19847569
references.citation: J Clin Oncol. 2008 Jan 20;26(3):350-1
references.pmid: 18202407
references.citation: Clin Exp Gastroenterol. 2009;2:49-60
references.pmid: 21694827
references.citation: World J Gastroenterol. 2007 Apr 28;13(16):2339-43
references.pmid: 17511034
references.citation: Ann Surg. 2005 Jul;242(1):74-82
references.pmid: 15973104
references.citation: Int J Colorectal Dis. 2009 Aug;24(8):923-9
references.pmid: 19488771
references.citation: World J Gastroenterol. 2011 Feb 21;17(7):862-6
references.pmid: 21412496
references.citation: Ann Surg. 2004 Aug;240(2):260-8
references.pmid: 15273550
references.citation: Can J Surg. 2004 Apr;47(2):130-7
references.pmid: 15132469
references.citation: Radiology. 2004 Apr;231(1):91-9
references.pmid: 14976266
references.citation: World J Gastrointest Surg. 2010 Apr 27;2(4):95-100
references.pmid: 21160857
references.citation: Ann Surg. 2003 Mar;237(3):335-42
references.pmid: 12616116
references.citation: J Clin Oncol. 2004 Oct 1;22(19):3958-64
references.pmid: 15459218
references.citation: Br J Cancer. 2000 Mar;82(6):1131-7
references.pmid: 10735495
references.citation: Int Neurourol J. 2011 Sep;15(3):166-71
references.pmid: 22087426
references.citation: Chirurgia (Bucur). 2014 May-Jun;109(3):375-82
references.pmid: 24956344
references.citation: World J Surg Oncol. 2015 Jan 24;13:9
references.pmid: 25617234
references.citation: J Clin Oncol. 2013 Dec 1;31(34):4276-82
references.pmid: 24166526
references.citation: World J Gastrointest Endosc. 2014 May 16;6(5):209-19
references.pmid: 24891934
references.citation: Clin Colon Rectal Surg. 2007 Aug;20(3):190-202
references.pmid: 20011200
references.citation: Arch Pathol Lab Med. 2009 Oct;133(10):1539-51
references.pmid: 19792043
references.citation: JSLS. 2009 Oct-Dec;13(4):564-73
references.pmid: 20202399
references.citation: Minim Invasive Surg. 2013;2013:687134
references.pmid: 23577248
references.citation: JSLS. 2005 Apr-Jun;9(2):184-8
references.pmid: 15984707
references.citation: Radiat Oncol. 2014 Jul 22;9:159
references.pmid: 25052511
references.citation: JSLS. 2007 Apr-Jun;11(2):204-7
references.pmid: 17761081
references.citation: J Clin Oncol. 2004 May 15;22(10):1785-96
references.pmid: 15067027
references.citation: Ann Surg. 2000 Mar;231(3):345-51
references.pmid: 10714627
references.citation: Front Oncol. 2014 May 06;4:98
references.pmid: 24834429
references.citation: Surg Endosc. 2013 Sep;27(9):3165-72
references.pmid: 23519489
references.citation: J Clin Oncol. 2004 Jan 15;22(2):217-9
references.pmid: 14665616